Compare Medtronic PLC (MDT) vs Msci Inc (MSCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Msci Inc — how do they compare? Medtronic PLC trades at $87.75 (market cap $112.24B), while Msci Inc trades at $561.75 (market cap $40.38B). The key difference: Medtronic PLC is far larger — about 2.8× Msci Inc's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Msci Inc for 82 Days on average.
| MDT | MSCI | |
|---|---|---|
Market Cap | $112.24B | $40.38B |
Volume | 105,663,236 | 414,140 |
Sector | Health | Financials |
52-Week High | $105.35 | $643.83 |
52-Week Low | $73.75 | $511.84 |
Typical Hold Time | 63 Days | 82 Days |
Enterprise Value | $131.58B | $46.54B |
Dividend Yield | 3.28% | 1.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $85.51, down 1.81% on the day, with the stock showing bearish technical signals despite strong fundamental performance. The company has beaten earnings expectations for three consecutive quarters, maintains a healthy 13.93% net income margin, and offers a solid 3.2% dividend yield with 49 consecutive years of dividend growth. Recent positive developments include FDA clearances for new medical technologies and raised full-year guidance.
MDT presents a compelling value opportunity with analyst consensus pointing to 14% upside to the $97.80 price target. The stock's current valuation multiples (P/E 21.61, P/S 3.01) appear reasonable given the company's stable revenue growth and strong cash flow generation. Key risks include increasing debt levels and competitive pressures in the medical device sector, but the company's dividend aristocrat status and improving operational performance support a positive long-term outlook.
MSCI trades at $555.38, up 0.08% on the day, with a neutral technical signal. The stock shows strong fundamentals with a 40.73% net income margin and consistent revenue growth, reaching $3.13B in 2025. Recent earnings beat expectations in Q4 2025 and Q1 2026, though Q2 2026 missed slightly. Analyst sentiment is bullish with a 74% buy rating and a $701.71 consensus price target, suggesting significant upside. The company maintains robust cash flow from operations at $1.59B in 2025.
Outlook remains positive due to high profitability and analyst confidence, but risks include elevated valuation multiples and high long-term debt of $4.51B. The upcoming Q3 2026 earnings call on October 20, 2026, will be a key catalyst. Investors should weigh the strong growth trajectory against debt levels and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Msci Inc
MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →
